SCHEMBL1134523

SCHEMBL1134523

COc1ccc(C(CCCNC(=O)OC(C)(C)C)C(N)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA12 O43570 5/20 0.47
CA9 Q16790 5/20 0.47
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
BRD4 O60885 4/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
DYRK1A Q13627 1/20 0.41
GPR88 Q9GZN0 1/20 0.41
DRD2 P14416 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586630 0.91 MEN1 (0.49) MEN1GAAKMT2ACA1CA2
SCHEMBL25496749 0.85 GAA (0.54) MEN1GAAKMT2ACA1CA2
SCHEMBL1134591 0.83 MEN1 (0.49) MEN1GAAKMT2ACA1CA2
SCHEMBL29182092 0.81 GAA (0.49) MEN1GAAKMT2ACA1CA2
SCHEMBL219771 0.80 AKR1C3 (0.56) MEN1GAAKMT2ABRD4DYRK1A
SCHEMBL10639498 0.78 MEN1 (0.49) MEN1GAAKMT2ACA1CA2
SCHEMBL27495544 0.76 MMP13 (0.53) CA1CA2MMP2MMP9HDAC1
SCHEMBL30771280 0.76 PPARG (0.46) MEN1GAAKMT2AGPR88
SCHEMBL31724161 0.76 NPSR1 (0.43) KMT2ACA1CA2CA12CA9
SCHEMBL7344378 0.76 MEN1 (0.62) MEN1GAAKMT2ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285785-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES Novartis AG (CH) 2011-02-23 EP disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO disclosed